Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- Pharma Roundup: Merck Gets Transparent, Pfizer Mulls Layoffs, and More
- Merck latest to announce transparency policies -- As the Physician Payments Sunshine Act approaches Congressional approval, Merck has announced a plan to publicize the grants they offer medical organizations and speakers. Earlier this week, Lilly made a similar promise, and several other pharma companies have recently retooled their disclosure policies....
- Blog posts 2008-09-25
- As Boehringer Develops Viagra for Women, History Suggests High Risk of Failure
- Boehringer Ingelheim is developing a female version of Viagra -- and wading into an infamous graveyard of failed pharma products. Like cures for obesity, therapies to boost flagging libido in women are better known for their failures than their successes. by Jim Edwards
- Blog posts 2009-11-13
Additional Resources
- Houston, Texas-based speciality chemicals provider KMG Chemicals has acquired the US-based animal insecticide business of Boehringer Ingelheim Vetmedica, an affiliate of the Boehringer Ingelheim group, headquartered in Ingelheim, Germany and which holds 2
- Houston, Texas-based speciality chemicals provider KMG Chemicals has acquired the US-based animal insecticide business of Boehringer Ingelheim Vetmedica, an affiliate of the Boehringer Ingelheim group, headquartered in Ingelheim, Germany and which holds 20% of the US livestock and poultry insecticide business. KMG expects the purchase, for an undisclosed sum, to...
- Research articles 2006-03-06
- Boehringer Ingelheim Pharmaceuticals renews grant for science mentoring program at Yale.
- M2 PRESSWIRE-4 March 2002-YALE UNIVERSITY: Boehringer Ingelheim Pharmaceuticals renews grant for science mentoring program at Yale C1994-2002 M2 COMMUNICATIONS LTD RDATE:04032002 New Haven, Conn. -- Funding of Yale University's flagship program for broadening access to the sciences by identifying and ...
- Research articles 2002-03-04
- Ingenuity Systems Announces Licensing Agreement with Boehringer Ingelheim.
- REDWOOD CITY, California, April 18 /PRNewswire/ -- - Ingenuity Pathways Analysis Will Be Incorporated Into Boehringer Ingelheim's Global Research Practices Ingenuity Systems today announced that they have entered into an agreement with Boehringer Ingelheim for global access to Ingenuity Pathways Analysis...
- Research articles 2006-04-18
- Lexicon Genetics extends gene targeting technology agreement.(OmniBank Universal)(Boehringer Ingelheim Pharmaceuticals Inc.)(Brief Article)
- Lexicon Genetics, Inc. (The Woodlands, TX) has extended its OmniBank Universal agreement with Boehringer Ingelheim Pharmaceuticals, Inc. Under the terms of the agreement, Boehringer Ingelheim will continue its access to Lexicon's OmniBank library through February 2004. Boehringer Ingelheim will also continue to have access...
- Research articles 2003-03-01
- Merial and Boehringer Ingelheim Vetmedica Inc. announce a co-marketing agreement for the Merial SUREHEALTH calf-preconditioning program
- Merial and Boehringer Ingelheim Vetmedica Inc. announce a co-marketing agreement for the Merial SUREHEALTH calf-preconditioning program. The SUREHEALTH program features best management practices that add value to feeder calves throughout the production chain. As part of the agreement, the number of qualified products will grow to include brands from both...
- Research articles 2005-03-01
- Boehringer Ingelheim Submits Marketing Authorisation Application to European Union and to the FDA for Investigational Anti-HIV Agent Tipranavir.
- INGELHEIM, Germany, October 25 /PRNewswire/ -- Boehringer Ingelheim today announced the submission of a Marketing Authorisation Application MAA to the European Medicines Agency EMEA for tipranavir. Simultaneously the documentation was submitt INGELHEIM, Germany, October 25 /PRNewswire/ -- Boehringer...
- Research articles 2004-10-25
- LILLY (ELI) & COMPANY - Statement re LLY and Boehringer Ingelheim.
- Eli Lilly and Company Boehringer Ingelheim GmbH Lilly Corporate Center 55216 Ingelheim Indianapolis, Indiana Germany ...
- Research articles 2006-02-15
- Boehringer Ingelheim and 8 Other Companies Caught Selling Illegal Painkillers
- The FDA has banned Boehringer Ingelheim and eight other drug companies from selling illegal, unapproved pain drugs. The drugs removed from the market include high concentrate morphine sulfate oral solutions, hydromorphone and oxycodone. The FDA: "Consumers have a right to expect that their drugs meet the...
- Blog posts 2009-04-01
- Tepnel signs R&D agreement with Boehringer Ingelheim.
- 2 February 2005 Tepnel Life Sciences PLC - Research and Development Collaboration Tepnel Life Sciences PLC (`Tepnel') signs R&D agreement with Boehringer ...
- Research articles 2005-02-02
- Boehringer Ingelheim Vetmedica Japan Begins Distributing Animal
- Tokyo, July 4, 2006 - JCN - Boehringer Ingelheim Vetmedica Japan, a wholly owned subsidiary of Nippon Boehringer Ingelheim, began distributing animal health products through its own sales channel on July 1. As an initial step, the company will market two products, a veterinary drug called METACAM...
- Research articles 2006-07-04
- GE, Boehringer donate $15,000.(GE Commercial Finance and Boehringer Ingelheim for Danbury State Scholars Program )(Brief Article)
- The Danbury State Scholars Program has received a $15,000 donation--$10,000 from GE Commercial Finance and $5,000 from Boehringer Ingelheim--for the creation of an academic enhancement lab at Danbury High School. The lab will support students who are The Danbury State Scholars Program has received a $15,000...
- Research articles 2005-05-16
- Boehringer Ingelheim Presented 2004 Frost & Sullivan Customer Value Award.
- LONDON, England, February 17 /PRNewswire/ -- The 2004 Frost & Sullivan Customer Value Award is presented to Germany headquartered Boehringer Ingelheim for providing its clients in the global biopharmaceutical manufacturing market with the hig LONDON, England, February 17 /PRNewswire/ -- ...
- Research articles 2005-02-17
- Boehringer Ingelheim Ups SSP Stake in Wake of OTC Deregulation Trend.
- NIPPON BOEHRINGER Ingelheim Co. Ltd., the Japanese subsidiary of the major German pharmaceutical company, has launched a tender offer for additional shares of SSP Co. Ltd., a Japanese drug manufacturer. The offer, which would increase the company's NIPPON BOEHRINGER Ingelheim Co. Ltd., the Japanese...
- Research articles 2000-01-24
- Eli Lilly, BI form drug pact in stress urinary incontinence. (Life Sciences).(Boehringer Ingelheim GmbH)
- ELI LILLY and Company has inked a long-term agreement with Boehringer Ingelheim GmbH BI to jointly commercialize duloxetine, a key player in Lilly's crowded pipeline. The pact, Lilly's first major copromotion deal for an in-house product, lays th ELI LILLY and Company has inked...
- Research articles 2002-12-16
- InterMune Transfers Manufacturing to BI.(Boehringer Ingelheim)(Brief Article)
- TO IMPROVE manufacturing capacity for its interferon product, InterMune Inc. has gained Food and Drug Administration approval to transfer manufacturing of Actimmune (interferon gamma-lb) from Genentech Inc. to Boehringer Ingelheim BI Austria GmbH TO IMPROVE manufacturing capacity for its interferon product, InterMune Inc....
- Research articles 2001-10-01
- Yale celebrates ten years of STARS with support from Boehringer Ingelheim.
- M2 PRESSWIRE-6 March 2006-YALE UNIVERSITY: Yale celebrates ten years of STARS with support from Boehringer IngelheimC1994-2006 M2 COMMUNICATIONS LTD RDATE:06032006 New Haven, Conn. -- For 10 years the STARS (Science, Technology and Research Scholars) program at Yale University, supported by Boehringer Ingelheim Pharmaceuticals, Inc. BIPI and...
- Research articles 2006-03-06
- YALE UNIVERSITY: Boehringer Ingelheim provides grant to Yale to support diversity in science.
- M2 PRESSWIRE-16 September 1999-YALE UNIVERSITY: Boehringer Ingelheim provides grant to Yale to support diversity in science C1994-99 M2 COMMUNICATIONS LTD RDATE:150999 New Haven, Conn. -- Yale today received a $100,000 grant from Boehringer Ingelheim Pharmaceuticals, Inc., to support STARS (Science, ...
- Research articles 1999-09-16
- Boehringer Ingelheim Implements SSA's BPCS At 25 Sites to Support Manufacturing, Distribution, Finance Operations
- CHICAGO--BUSINESS WIRE--Aug. 23, 1999-- Migration to eBPCS and Portfolio Strategy in Future Plans for Privately-Held Pharmaceutical Company Privately-held German pharmaceutical and chemical manufacturer, Boehringer Ingelheim, has implemented System Software Associates' (NASDAQ: SSAX) BPCS product suite at 25 locations throughout Europe, North and Latin America, and the Far...
- Research articles 1999-08-23
- << Previous
- page 1 of 1
- Next >>
